- Conditions
- Autism, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD), Neurodevelopmental Conditions
- Interventions
- BlinkLab Dx1, Retrospective Neurodevelopmental Diagnostic Assessment
- Diagnostic Test · Behavioral
- Lead sponsor
- Blinklab Limited
- Industry
- Eligibility
- 2 Years to 11 Years
- Enrollment
- 1,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Princeton, New Jersey
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–11
of 11
matching trials from the local directory fallback.
Local D1 index available.
- Conditions
- Autism Spectrum Disorder (ASD), Bi-Polar Disorder, Generalized Anxiety Disorder (GAD), Major Depression Disorders, Separation Anxiety Disorder, Social Anxiety Disorder
- Interventions
- Digital software application for cognitive performance and activity measurement (QbMobile, investigational device)
- Device
- Lead sponsor
- Qbtech AB
- Industry
- Eligibility
- 6 Years to 60 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- 22q11.2 Deletion Syndrome, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD, Cerebral Palsy (CP), Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance Impairment, Cerebral Palsy Infantile, Cerebral Palsy Spastic Hemiplegic, Cerebral Palsy, Dyskinetic, Chromosomal Abnormalities, Developmental Delay (Disorder), Down Syndrome (Trisomy 21), Fragile X Syndrome (FXS), Genetic Disorders, Hypoxic Ischemic Encephalopathy, Hypoxic Ischemic Encephalopathy (HIE), Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD), Neurodevelopmental Disorders and Developmental Abnormalities, RETT Syndrome With Proven MECP2 Mutation, Sensorimotor Integration, Sensory Processing Disorder, Traumatic Brain Injury (TBI), Williams Syndrome
- Interventions
- Not listed
- Lead sponsor
- Healing Hope International
- Other
- Eligibility
- 4 Years to 12 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2036
- U.S. locations
- 1
- States / cities
- The Woodlands, Texas
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD)
- Interventions
- L-theanine and paraxanthine, Placebo
- Dietary Supplement
- Lead sponsor
- Texas Tech University Health Sciences Center
- Other
- Eligibility
- Male only
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Lubbock, Texas
- Conditions
- Autism Spectrum Disorder (ASD), Motivation
- Interventions
- Combined Intrinsic and Extrinsic Motivation Treatment, Extrinsic Motivation Treatment, Intrinsic Motivation Treatment
- Behavioral
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 16 Years to 25 Years
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Autism, Autism Spectrum Disorder (ASD)
- Interventions
- Sleep Restriction Therapy
- Behavioral
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 6 Years to 12 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Autism, Autism Spectrum Disorder (ASD)
- Interventions
- Developmental Reciprocity Treatment (DRT), Early Start Denver Model (ESDM), Pivotal Response Treatment (PRT)
- Behavioral
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 2 Years to 4 Years
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2037
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Autism Spectrum Disorder (ASD)
- Interventions
- ¡Iniciando! mHealth App
- Behavioral
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years to 25 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- ASD, Autism, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD)
- Interventions
- Glutathione, Umbilical Cord Blood-Derived Stem Cells and Exosomes
- Drug · Biological
- Lead sponsor
- Adia Med of Winter Park LLC
- Other
- Eligibility
- 3 Years to 12 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Winter Park, Florida
- Conditions
- Autism Spectrum Disorder, Autism Spectrum Disorder (ASD), Autism Spectrum Disorder High-Functioning, Autism Spectrum Disorder With Absence of Functional Language, Autism Spectrum Disorder With Impaired Functional Language, Autistic Disorder, Autistic Disorder in Children and Adolescents, Autistic Disorder of Childhood Onset With Full Syndrome, Autistic Disorders Spectrum, Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD), Neurodevelopmental Disorders and Developmental Abnormalities
- Interventions
- Not listed
- Lead sponsor
- Healing Hope International
- Other
- Eligibility
- 4 Years to 21 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Spring, Texas
- Conditions
- Asperger's, Asperger's Disorder, Autism, Autism Spectrum Disorder (ASD), Autistic Disorder, Pediatric Autism, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
- Interventions
- Memantine Hydrochloride (HCl)
- Drug
- Lead sponsor
- Forest Laboratories
- Industry
- Eligibility
- 6 Years to 12 Years
- Enrollment
- 747 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 68
- States / cities
- Dothan, Alabama • Phoenix, Arizona • Tucson, Arizona + 62 more